In addition, antibodies targeting clusterin, a stress-activated and apoptosis-associated molecular chaperone also overexpressed in breast cancer [135], have been reported to inhibit TGF-β-induced EMT and to reduce lung metastasis in breast cancer models [136,137]. This evidence concerns the gene TGFB1 and breast carcinoma.